Physician profile
Michelle Theresa Mccall
NPI 1144708827
$5,098.93
in general payments reported to CMS, 2019-2025
37 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $385 · 2022: $349 · 2023: $708 · 2024: $2,322 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,811 · Travel and Lodging: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,810.86 |
| Travel and Lodging | $554.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,215.33 | 2021-2024 | Axonics, Bulkamid |
| Teleflex LLC | $750.68 | 2024 | Urolift |
| Sumitomo Pharma America, INC. | $388.95 | 2024-2025 | Gemtesa, Orgovyx |
| Bluewind Medical | $345.26 | 2024-2025 | Revi |
| Ferring Pharmaceuticals INC. | $301.36 | 2024-2025 | Adstiladrin |
| Astellas Pharma US INC | $291.18 | 2021-2024 | Veozah, Xtandi |
| Medtronic, INC. | $195.99 | 2021-2025 | Interstim, Emprint |
| Immunitybio, INC. | $158.03 | 2025 | |
| Antares Pharma, INC. | $144.80 | 2024-2025 | Xyosted |
| Boston Scientific Corporation | $110.46 | 2024-2025 | Axonics, Rezum Generator, Lithovue |
| 180 Medical, INC. | $97.74 | 2021-2023 | |
| Urovant Sciences INC | $90.58 | 2021-2022 | |
| Urogen Pharma, INC. | $89.46 | 2024-2025 | |
| Janssen Biotech, INC. | $89.24 | 2025 | Rybrevant, Carvykti, Erleada |
| Convatec INC. | $86.71 | 2025 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Mccall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.